The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us
8th Floor John Pappajohn Pavilion
Iowa City IA 52242
(319) 356-2778

Release: Immediate

UIHC selected to test two new breast cancer drugs

IOWA CITY, Iowa -- The University of Iowa Hospitals and Clinics (UIHC) is one of 14 medical centers in the United States and Canada selected to evaluate two drugs in the treatment of breast cancer.

This is phase two of the study evaluating the effectiveness of using Adramycin and Taxotere in combination. The drugs are two of the most active single agents for treating metastatic breast cancer. The current study is designed to determine whether the drugs may be more effective in treating breast cancer when used together.

The study is conducted by the National Surgical Adjuvant Breast and Bowel Project and the National Cancer Institute. Surgical cancer specialist Dr. Peter Jochimsen will direct the study at the UIHC.

The study is expected to be open to accept patients in late May. For more information regarding the study, telephone the project coordinator, Mary Spaight, R.N. at (319) 356-2778.